abstract |
The invention relates to a new use of Lauryl Gallate (hereafter, LG) as an antiviral agent in the treatment and/or prevention of coronavirus infections and more particularly to human coronavirus infections, such as HCoV-229E or SARS-CoV-2 infections. |